We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

Download Mobile App




Image: SARS-CoV-2 viral particles (blue) in a clinical isolate. (Photo courtesy of CDC)

Discovery of Helpful and Harmful COVID-19-Related Genes to Aid Development of New Therapies

Additional COVID-19 related genes - both helpful and harmful - revealed in a massive screen will help guide efforts to develop new therapies. More...
28 Oct 2020
Illustration

Finger-Prick Tests Show Antibody Response to SARS-CoV-2 Reduces Over Time

Tests conducted on more than 365,000 people in the UK have shown that the antibody response to the SARS-CoV-2 virus that causes COVID-19 wanes over time. More...
28 Oct 2020
M.I ONE Co., Ltd
Image: Vivalytic SARS-CoV-2 rapid test (Photo courtesy of Randox Laboratories)

Randox and Bosch Healthcare Collaboratively Combat COVID-19 with Game-Changing Partnership

The game-changing partnership between Randox Laboratories (Crumlin, UK) and Bosch Healthcare (Waiblingen, Germany) continues to alter the testing landscape and capabilities of both laboratory and non-laboratory settings for rapidly detecting COVID-19. More...
28 Oct 2020
Image: Study to Examine Whether Rapid COVID-19 Antigen Tests Can Identify Infectious and Asymptomatic Individuals (Photo courtesy of (USC Photo/Gus Ruelas)

Study to Examine Whether Rapid COVID-19 Antigen Tests Can Identify Infectious and Asymptomatic Individuals

Researchers are using rapid COVID-19 antigen tests in a study to examine their use among first responders and school-aged children, as well as understand whether these tests can identify infectious and asymptomatic individuals. More...
28 Oct 2020
Illustration

Ortho Launches New VITROS SARS-CoV-2 Antigen Test for Accurate Mass-Scale Testing in Markets Accepting CE Mark

Ortho Clinical Diagnostics (Raritan, NJ, USA) has received CE Mark for its second COVID-19 antibody test - the VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Test (COVID-19 IgG antibody test). More...
28 Oct 2020
Radcal
Illustration

DiaSorin Launches New LIAISON SARS-CoV-2 Ag High-Throughput Antigen Test in Markets Accepting CE Mark

DiaSorin (Saluggia, Italy) has launched its new LIAISON SARS-CoV-2 Ag, a high-throughput antigen test available in markets accepting the CE Mark for quantitative detection of SARS-CoV-2 in symptomatic patients through nasal and nasopharyngeal swabs. More...
28 Oct 2020
Image: AstraZeneca-Oxford COVID-19 Experimental Vaccine Triggers Similar Protective Antibodies and T-Cells in Both Older and Younger Adults (Photo courtesy of AstraZeneca)

AstraZeneca-Oxford COVID-19 Experimental Vaccine Triggers Similar Protective Antibodies and T-Cells in Both Older and Younger Adults

Early trial results of AstraZeneca Plc’s (Cambridgeshire, England) COVID-19 vaccine candidate suggest that the group most vulnerable to serious illness and death could build immunity as the vaccine has been found to trigger protective antibodies and T-cells in older age groups. More...
27 Oct 2020
Copyright © 2000-2020 Globetech Media. All rights reserved.